BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 11, 2016
View Archived Issues
First preclinical data demonstrate mutant EGFR selectivity of new inhibitor
Read More
Novel antibody mixture inhibits tumor growth in MET-amplified models
Read More
Bayer Pharma presents preclinical data for the novel anti-TweakR antibody, BAY-356
Read More
Pfizer presents highlights of first quarter 2016
Read More
Ohr Pharmaceutical develops biodegradable microparticle AMD treatment OHR-3031
Read More
Stevia First to become Vitality Biopharma with focus on cannabinoid prodrugs
Read More
Cynata Therapeutics and apceth enter license option agreement
Read More
Aptinyx completes series A financing
Read More
Interim data from Avelas' phase Ib trial of AVB-620 surgical marker
Read More
Verona Pharma announces positive phase II results for RPL-554 in patients with COPD
Read More
WAVE advances exon 51 DMD candidate and extends research collaboration with University of Oxford
Read More
Galapagos initiates phase I trial of its potentiator compound GLPG-2451
Read More
CJ CheilJedang reports compounds to treat constipation
Read More
Vitae Pharmaceuticals discloses RORgamma inverse agonists
Read More
Dermira discloses phase II results for DRM-01
Read More
Ferrer to acquire Alexza Pharmaceuticals
Read More
Achaogen enters antibody collaboration with Crystal Bioscience
Read More
Iron chelator Apo-6856 improves memory in Alzheimer's disease model
Read More
Sun Pharma Advanced Research initiates phase I/II study of K-0706
Read More
MacroGenics and Pfizer announce first patient dosed with PF-0661008
Read More
Janssen plans phase IIb study of AL-335, odalasvir and simeprevir combinations for chronic HCV
Read More
FDA grants fast track status to KemPharm's KP-511
Read More
New pilot study explores use of ARA-290 for diabetic macular edema
Read More
US Phytotherapy conducting preclinical studies of PROACT-Z for Zika infection
Read More
Treating Leber's congenital amaurosis type 10 with RNA antisense oligonucleotide QR-110
Read More